The "text only" version in this language is not currently available.
Misoprostol as adjunct treatment to standard uterotonics for treatment of post-partum haemorrhage: A multicentre, double-blind randomised trial
This article reports on a study evaluating misoprostol used in conjunction with routine injectable uterotonics for treatment of postpartum hemorrhage. The findings do not support clinical use of 600mcg sublingual misoprostol in addition to standard injectable uterotonics for treatment of postpartum hemorrhage. Read the full abstract at The Lancet, Vol 375(9728):1808-1813.